UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (902) 902
science & technology (705) 705
life sciences & biomedicine (698) 698
prasugrel hydrochloride (611) 611
platelet aggregation inhibitors - therapeutic use (594) 594
ticlopidine - analogs & derivatives (566) 566
piperazines - therapeutic use (452) 452
thiophenes - therapeutic use (452) 452
male (447) 447
ticlopidine - therapeutic use (430) 430
female (410) 410
cardiovascular system & cardiology (401) 401
middle aged (355) 355
prasugrel (337) 337
aged (326) 326
cardiac & cardiovascular systems (326) 326
acute coronary syndrome - drug therapy (315) 315
treatment outcome (305) 305
clopidogrel (300) 300
adenosine - analogs & derivatives (280) 280
platelet aggregation inhibitors - adverse effects (265) 265
purinergic p2y receptor antagonists - therapeutic use (251) 251
adenosine - therapeutic use (237) 237
prasugrel hydrochloride - therapeutic use (237) 237
platelet aggregation inhibitors - administration & dosage (188) 188
piperazines - adverse effects (184) 184
thiophenes - adverse effects (184) 184
percutaneous coronary intervention (183) 183
abridged index medicus (182) 182
acute coronary syndromes (180) 180
ticlopidine - adverse effects (174) 174
hemorrhage - chemically induced (170) 170
pharmacology & pharmacy (162) 162
aspirin - therapeutic use (158) 158
ticagrelor (152) 152
acute coronary syndrome (147) 147
coronary heart disease (146) 146
risk factors (146) 146
ticlopidine - administration & dosage (144) 144
piperazines - administration & dosage (137) 137
thiophenes - administration & dosage (137) 137
platelet aggregation inhibitors - pharmacology (135) 135
drug therapy, combination (130) 130
platelet aggregation - drug effects (130) 130
cardiovascular (122) 122
piperazines - pharmacology (122) 122
blood platelets - drug effects (121) 121
cardiac patients (121) 121
peripheral vascular disease (120) 120
thiophenes - pharmacology (119) 119
acute coronary syndrome - therapy (118) 118
myocardial infarction - drug therapy (117) 117
blood platelets (116) 116
heart attacks (115) 115
hematology (113) 113
drug therapy (111) 111
prospective studies (108) 108
time factors (108) 108
care and treatment (106) 106
stents (106) 106
purinergic p2y receptor antagonists - adverse effects (102) 102
general & internal medicine (95) 95
cardiology (94) 94
prasugrel hydrochloride - adverse effects (94) 94
aspirin (92) 92
adult (91) 91
medicine, general & internal (90) 90
prasugrel hydrochloride - administration & dosage (87) 87
purinergic p2y receptor antagonists - administration & dosage (86) 86
randomized controlled trials as topic (83) 83
platelet function tests (81) 81
transluminal angioplasty (79) 79
purinergic p2 receptor antagonists (77) 77
thrombosis (77) 77
platelet aggregation inhibitors - pharmacokinetics (76) 76
angioplasty, balloon, coronary (73) 73
piperazines - pharmacokinetics (72) 72
ticlopidine - pharmacology (72) 72
thiophenes - pharmacokinetics (70) 70
cardiovascular diseases (69) 69
clinical trials as topic (69) 69
analysis (68) 68
follow-up studies (68) 68
animals (67) 67
administration, oral (66) 66
dose-response relationship, drug (66) 66
myocardial infarction - therapy (65) 65
retrospective studies (64) 64
acute coronary syndrome - mortality (63) 63
adenosine - adverse effects (63) 63
thrombosis - prevention & control (62) 62
cardiovascular disease (61) 61
double-blind method (61) 61
mortality (61) 61
patients (61) 61
percutaneous coronary intervention - adverse effects (61) 61
myocardial infarction (59) 59
purinergic p2y receptor antagonists - pharmacology (59) 59
acute coronary syndrome - blood (58) 58
clinical trials (58) 58
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (893) 893
German (24) 24
French (9) 9
Turkish (7) 7
Italian (6) 6
Spanish (6) 6
Polish (3) 3
Russian (2) 2
Czech (1) 1
Finnish (1) 1
Hungarian (1) 1
Japanese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA : the journal of the American Medical Association, ISSN 0098-7484, 06/2019, Volume 321, Issue 24, pp. 2414 - 2427
Journal Article
The New England journal of medicine, ISSN 1533-4406, 10/2019, Volume 381, Issue 16, pp. 1524 - 1534
Journal Article
Current vascular pharmacology, ISSN 1570-1611, 2019, Volume 17, Issue 1, pp. 35 - 40
Background: Various antiplatelet drugs are used following Acute Coronary Syndromes (ACS). Of them, adenosine diphosphate receptor P2Y12 inhibitors clopidogrel,... 
clopidogrel | Myocardial infarction | prasugrel | pharmacokinetics | ticagrelor | cytochrome P450 | pharmacogenetic | Pharmacology & Pharmacy | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Myocardial Infarction - blood | Humans | Receptors, Purinergic P2Y12 - drug effects | Biotransformation - genetics | Clopidogrel - pharmacokinetics | Purinergic P2Y Receptor Antagonists - adverse effects | Ticagrelor - adverse effects | Cytochrome P-450 CYP3A - genetics | Receptors, Purinergic P2Y12 - blood | Pharmacogenomic Variants | ATP Binding Cassette Transporter, Subfamily B - genetics | Platelet Aggregation Inhibitors - pharmacokinetics | Blood Platelets - drug effects | Platelet Aggregation Inhibitors - therapeutic use | Prasugrel Hydrochloride - pharmacokinetics | Ticagrelor - therapeutic use | Purinergic P2Y Receptor Antagonists - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Myocardial Infarction - diagnosis | Ticagrelor - pharmacokinetics | Purinergic P2Y Receptor Antagonists - pharmacokinetics | Cytochrome P-450 CYP2C19 - genetics | Treatment Outcome | Prasugrel Hydrochloride - adverse effects | ATP Binding Cassette Transporter, Subfamily B - metabolism | Prasugrel Hydrochloride - therapeutic use | Drug Resistance - genetics | Animals | Myocardial Infarction - drug therapy | Blood Platelets - metabolism | Cytochrome P-450 CYP3A - metabolism | Cytochrome P-450 CYP2C19 - metabolism | Clopidogrel - adverse effects | Clopidogrel - therapeutic use | Drugs | Pharmacodynamics | Adenosine | Heart attacks | Effectiveness | Genetic variability | Variability | Adenosine diphosphate | Pharmacology | Metabolism | Carboxylesterase | Inhibitors | Isoforms | Clopidogrel | Infarction | Metabolic pathways | Genetic factors | Pharmacokinetics | Platelets
Journal Article
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 11/2016, Volume 134, Issue 21, pp. 1603 - 1612
Journal Article
The New England journal of medicine, ISSN 1533-4406, 10/2012, Volume 367, Issue 14, pp. 1297 - 1309
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 09/2012, Volume 108, Issue 3, pp. 412 - 414
Central adjudication in randomised controlled outcome-driven trials represents a traditional approach to maintain data integrity by applying uniformed rules... 
Clinical trials | rosiglitazone | prasugrel | ticagrelor | myocardial infarction | event adjudication | Current Controversies | Myocardial infarction | Prasugrel | Rosiglitazone | Event adjudication | Ticagrelor | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Prasugrel Hydrochloride | Thiophenes - therapeutic use | Myocardial Infarction - epidemiology | Metformin - therapeutic use | Randomized Controlled Trials as Topic - methods | Humans | Clinical Trials, Phase III as Topic - methods | Randomized Controlled Trials as Topic - standards | Clinical Trials, Phase III as Topic - standards | Multicenter Studies as Topic - methods | Thiazolidinediones - therapeutic use | Hypoglycemic Agents - administration & dosage | Adenosine - therapeutic use | Cardiovascular Diseases - mortality | Sulfonylurea Compounds - administration & dosage | Metformin - administration & dosage | Stroke - mortality | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Judgment | Hypoglycemic Agents - therapeutic use | Myocardial Infarction - diagnosis | Double-Blind Method | Sulfonylurea Compounds - therapeutic use | Combined Modality Therapy | Piperazines - therapeutic use | Outcome Assessment (Health Care) - standards | Acute Coronary Syndrome - drug therapy | Process Assessment (Health Care) | Adenosine - analogs & derivatives | Acute Coronary Syndrome - therapy | Myocardial Infarction - prevention & control | Diabetes Mellitus, Type 2 - drug therapy | Observer Variation | Percutaneous Coronary Intervention
Journal Article